BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2832050)

  • 21. Phenylhydrazine stimulates lymphopoiesis and accelerates Abelson murine leukemia virus-induced pre-B cell lymphomas.
    Klinken SP; Holmes KL; Fredrickson TN; Erner SM; Morse HC
    J Immunol; 1987 Nov; 139(9):3091-8. PubMed ID: 2822804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of A-MuLV transformed fibroblast lines for amplification of the c-myc, p53 and c-fos nuclear proto-oncogenes.
    Colledge WH; Gebhardt A; Edge MD; Bell JC
    Oncogene; 1989 Jun; 4(6):753-7. PubMed ID: 2543944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation of Abelson murine leukemia virus-infected promonocytic leukemia cells.
    Hines DL
    Int J Cancer; 1985 Aug; 36(2):233-9. PubMed ID: 4018913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of multiple hemopoietic growth factor genes in Abelson virus-transformed myeloid cells.
    Humphries RK; Abraham S; Krystal G; Lansdorp P; Lemoine F; Eaves CJ
    Exp Hematol; 1988 Oct; 16(9):774-81. PubMed ID: 2844575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Abelson murine leukemia virus oncogene.
    Goff SP
    Proc Soc Exp Biol Med; 1985 Sep; 179(4):403-12. PubMed ID: 2991935
    [No Abstract]   [Full Text] [Related]  

  • 26. BP-1/6C3 expression defines a differentiation stage of transformed pre-B cells and is not related to malignant potential.
    Ramakrishnan L; Wu Q; Yue A; Cooper MD; Rosenberg N
    J Immunol; 1990 Sep; 145(5):1603-8. PubMed ID: 1974567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Friend murine leukemia virus-immortalized myeloid cells are converted into tumorigenic cell lines by Abelson leukemia virus.
    Oliff A; Agranovsky O; McKinney MD; Murty VV; Bauchwitz R
    Proc Natl Acad Sci U S A; 1985 May; 82(10):3306-10. PubMed ID: 2987918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity.
    Reddy EP; Smith MJ; Srinivasan A
    Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3623-7. PubMed ID: 6304726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation and characterization of temperature-sensitive mutants of Abelson murine leukaemia virus that exhibit dissociation among morphological transformation, soft agar colony-forming ability and tyrosine kinase activity.
    Oka Y; Sugiyama H; Tsukada S; Shimizu Y; Inoue H; Hakura A; Kishimoto S
    J Gen Virol; 1989 Sep; 70 ( Pt 9)():2527-32. PubMed ID: 2550581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of an Abelson virus-transformed immature B precursor cell line under the expression of tyrosine kinase activity of v-abl oncogene product.
    Maeda T; Owada MK; Sugiyama H; Miyake S; Tani Y; Ogawa H; Oka Y; Komori T; Soma T; Kishimoto S
    Cell Differ; 1987 Apr; 20(4):263-9. PubMed ID: 2438051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and characterization of Abelson murine leukemia virus-transformed mast cell lines from midgestation embryonic placenta.
    Siegel ML; Horwitz R; Morris TD; Di Venere RM; Siden EJ
    Eur J Immunol; 1985 Nov; 15(11):1136-41. PubMed ID: 2998805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone marrow-transforming activity of linker insertion mutants of Abelson murine leukemia virus.
    Hevezi P; Alin K; Rees-Jones R; Goff SP
    Oncogene; 1992 Nov; 7(11):2323-8. PubMed ID: 1437154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromosomal assignment of the endogenous proto-oncogene C-abl.
    Goff SP; D'Eustachio P; Ruddle FH; Baltimore D
    Science; 1982 Dec; 218(4579):1317-9. PubMed ID: 6293057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity.
    Engelman A; Rosenberg N
    J Virol; 1990 Sep; 64(9):4242-51. PubMed ID: 1696637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abelson virus transformation of an interleukin 2-dependent antigen-specific T-cell line.
    Cook WD; Fazekas de St Groth B; Miller JF; MacDonald HR; Gabathuler R
    Mol Cell Biol; 1987 Jul; 7(7):2631-5. PubMed ID: 3039352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insertional mutagenesis of the Abelson murine leukemia virus genome: identification of mutants with altered kinase activity and defective transformation ability.
    Rees-Jones RW; Goff SP
    J Virol; 1988 Mar; 62(3):978-86. PubMed ID: 2828693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the human ABL promoter regions.
    Zhu QS; Heisterkamp N; Groffen J
    Oncogene; 1990 Jun; 5(6):885-91. PubMed ID: 2163052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. bcr/abl and src but not myc and ras replace v-abl in lymphoid transformation.
    Engelman A; Rosenberg N
    Mol Cell Biol; 1990 Aug; 10(8):4365-9. PubMed ID: 2164639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abelson murine leukemia virus: molecular cloning of infectious integrated proviral DNA.
    Srinivasan A; Reddy EP; Aaronson SA
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2077-81. PubMed ID: 6264461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular RNA homologous to the Abelson murine leukemia virus transforming gene: expression and relationship to the viral sequence.
    Wang JY; Baltimore D
    Mol Cell Biol; 1983 May; 3(5):773-9. PubMed ID: 6306446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.